Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AURA Aura Biosciences > Detailed Quotes

AURA Aura Biosciences

Watchlist
11.900
-0.210-1.73%
Trading Session  02/08 10:58 ET
High
12.080
Open
12.080
Turnover
80.21K
Low
11.738
Pre Close
12.110
Volume
6.73K
Market Cap
428.81M
P/E(TTM)
Loss
52wk High
24.830
Shares
36.03M
P/E(Static)
Loss
52wk Low
9.430
Float Cap
208.48M
Bid/Ask %
0.00%
Historical High
26.160
Shs Float
17.52M
Volume Ratio
0.26
Historical Low
9.430
Dividend TTM
--
Div Yield TTM
--
P/B
3.73
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.04%
Amplitude
2.83%
Avg Price
11.923
Lot Size
1
Float Cap
208.48M
Bid/Ask %
0.00%
Historical High
26.160
Shs Float
17.52M
Volume Ratio
0.26
Historical Low
9.430
Dividend TTM
--
P/B
3.73
Dividend LFY
--
Turnover Ratio
0.04%
Amplitude
2.83%
Avg Price
11.923
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.
CEO: Ms. Elisabet de los Pinos
Market: NASDAQ
Listing Date: 10/29/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist